sodium oxybate
NDC 72865-349, sodium oxybate, solution, from XLCare Pharmaceuticals, Inc..
- Product NDC
- 72865-349
- Status
- Listed
- Labeler
- XLCare Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210523
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/72865-349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM OXYBATE.5 g/mL
Pharmacologic classes
Central Nervous System Depressant [EPC]; Central Nervous System Depression [PE]; Decreased Central Nervous System Organized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72865-349-18 | 72865034918 | 1 BOTTLE in 1 CARTON (72865-349-18) / 180 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c0fb2620-7247-464d-a37a-8b516ce7d563
Use it
Look up 72865-349 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72865-349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72865-349. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.